challenge

(redirected from bronchial challenge)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to bronchial challenge: Bronchial Provocation Test

challenge

1. US an assertion that a person is not entitled to vote or that a vote is invalid
2. Law a formal objection to a person selected to serve on a jury (challenge to the polls) or to the whole body of jurors (challenge to the array)

challenge

[′chal·ənj]
(communications)
To cause an interrogator to transmit a signal which puts a transponder into operation.
(immunology)
Administration of an antigen to ascertain state of immunity.
Mentioned in ?
References in periodicals archive ?
With the ARIDOL-specific J-code in effect, office-based physicians who would like to use the dry powder bronchial challenge test and providers who currently use ARIDOL have a product-specific code to submit to payers which often increases the efficiency of the reimbursement process," said Stephen Beckman, President, Pharmaxis, Inc.
Pharmaxis Announces ARIDOL[R] (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code
We measured responsiveness to methacholine 8 hr after the allergen bronchial challenge ended.
Effect of formaldehyde on asthmatic response to inhaled allergen challenge
The J-code should facilitate reimbursement for providers who currently use bronchial challenge tests as part of their asthma assessment protocol, as well as for office-based physicians that would like to offer ARIDOL due to its ease of administration.
Pharmaxis Receives J-Code For ARIDOL (Mannitol Inhalation Powder) Bronchial Challenge Test Kit
About 63% of the children studied had a negative SPT and a negative bronchial challenge test.
The relationship between air pollution from heavy traffic and allergic sensitization, bronchial hyperresponsiveness, and respiratory symptoms in Dutch schoolchildren
ARIDOL is an important advancement in bronchial challenge testing - the first in 20 years - and a significant addition to the tools available to help in an overall assessment of asthma," said Stephen Beckman, President, Pharmaxis, Inc.
Pharmaxis Launches ARIDOL (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
SYDNEY, Australia, May 13 /PRNewswire-Asia/ -- Pharmaxis ( NASDAQ: PXSL) today announced it had received notification from the United States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol bronchial challenge test Aridol(TM) has been accepted for standard review.
U.S. FDA Accepts Aridol(TM) New Drug Application for Review
The French bronchial challenge testing market is dominated by methacholine and more than 25,000 tests are conducted annually with little recent innovation in the field.
Pharmaxis Appoints French Distributor for Aridol(TM)
Food and Drug Administration (FDA) for Aridol(TM) (mannitol bronchial challenge test).
Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)
Food and Drug Administration (FDA) for Aridol, a bronchial challenge test.
Pharmaxis Announces New Drug Application Submission for Aridol(TM)

Encyclopedia browser ?
Full browser ?